GLYCAN MEDIATED REGULATION OF CD44 FUNCTION
GLYCAN MEDIATED REGULATION OF CD44 FUNCTION
批准号:
2796334
负责人:
TIMOTHY P SKELTON
金额:
$7.89万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 2000-09-29
关键词:
CD44 molecule CHO cells capillary electrophoresis carbohydrate structure cell adhesion cell adhesion molecules cell type chemical binding chemical structure function enzyme activity enzyme substrate flow cytometry glycosylation glycosyltransferase hyaluronate laboratory mouse leukocyte activation /transformation messenger RNA metastasis neoplastic cell oligosaccharides phosphorylation sialyltransferases transfection
中文摘要
描述(申请人描述):大多数人类癌症死亡病例
是由于转移,这一过程在分子水平上知之甚少
和细胞水平。在多步骤的转移过程中,人们可以预料到
细胞黏附分子的重要作用。CD44,一种细胞表面
透明质酸(HA)受体在细胞黏附中的作用
迁移和细胞激活被牵连到了
转移。CD44具有调节其配体亲和力的特性。
糖基化在调节CD44介导的透明质酸结合中的作用
因此将被审查。这项研究与候选人的研究是一致的
长期目标是阐明足够详细的机制,通过它
糖基化调节细胞黏附分子功能以实现调节
这一机制作为对转移的干预。初步研究
已经确定了影响内源性的寡糖结构
CD44的HA结合特性。本提案的目的是确定
结构受到生物调节,并阐明酶的基础
对于功能调节来说,I是重要的糖链结构。之后
关键糖基转移酶的鉴定,其作用机制
作为整合细胞行为的一部分,细胞调节CD44糖基化
将会被定义。要研究的机制包括合成的
糖基转移酶表达、糖基转移酶磷酸化、CD44
选择性的RNA剪接和相互作用的糖基转移酶。CD44
寡糖结构将通过糖苷酶消化和
糖基转移酶调节。固有的CD44 HA亲和力将是
采用亲和毛细管电泳法测定。结构/功能
将会得出相关的结论。CD44糖基化和CD44的生理性改变
透明质酸亲和力将在细胞激活时进行测试。对以下方面的影响
糖基转移酶调控CD44 HA亲和力的转移
调制将使用体内模型来确定。这项提议将
作为制定定义法规的一般方法的基础
糖基化在细胞-细胞和细胞-基质黏附中的作用。
英文摘要
DESCRIPTION (Applicant's Description): The majority of human cancer deaths
are due to metastasis, a process that is poorly understood at the molecular
and cellular levels. In the multistep process of metastasis one expects
significant roles for cell adhesion molecules. CD44, a cell surface
receptor for hyaluronan (HA) that functions in cell adhesion, cell
migration, and cell activation, has been implicated in the process of
metastasis. CD44 has the property of regulated affinity for its ligand.
The role of glycosylation in regulating CD44-mediated hyaluronan binding
will therefore be examined. This study is consistent with the candidate's
long-term objective of elucidating enough detail of the mechanism by which
glycosylation regulates cell adhesion molecule function to enable modulation
of this mechanism as an intervention f o r metastasis. Preliminary studies
have identified oligosaccharide structures which impact the intrinsic
HA-binding properties of CD44. The present proposal aims to determine which
structures are biologically regulated and to elucidate the enzymatic basis
for regulation of the functionally i m portant glycan structure. After
identification of the key glycosyltransferase, the mechanism employed by the
cell to regulate CD44 glycosylation as part of an integrated cell behavior
will be defined. Mechanisms to be examined include synthetic
glycosyltransferase expression, glycosyltransferase phosphorylation, CD44
alternative RNA splicing, and interacting glycosyltransferases. CD44
oligosaccharide structure will be c h a n ged by glycosidase digestion and
glycosyltransferase modulation. I n t rinsic CD44 HA-affinity will be
determined by affinity capillary e l e ctrophoresis. Structure/function
correlations will be drawn. A physiologic change in CD44 glycosylation and
hyaluronan-affinity will be tested upon cellular activation. The effects on
metastasis of manipulating CD44 HA-affinity by glycosyltransferase
modulation will be determined using an in vivo model. This proposal will
serve as a basis to develop a general approach to defining the regulatory
role of glycosylation in cell-cell and cell-matrix adhesion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DECODING CANCER SIGNATURE GLYCOFORMS OF SERUM TUMOR MARK
-
批准号:6287265
-
项目类别:
-
资助金额:$4.37万
-
财政年份:2001
-
负责人:TIMOTHY P SKELTON
-
依托单位:
DECODING CANCER SIGNATURE GLYCOFORMS OF SERUM TUMOR MARK
-
批准号:6540881
-
项目类别:
-
资助金额:$4.28万
-
财政年份:2001
-
负责人:TIMOTHY P SKELTON
-
依托单位:
DECODING CANCER SIGNATURE GLYCOFORMS OF SERUM TUMOR MARK
-
批准号:6489429
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2001
-
负责人:TIMOTHY P SKELTON
-
依托单位:
GLYCAN MEDIATED REGULATION OF CD44 FUNCTION
-
批准号:2402752
-
项目类别:
-
资助金额:$7.89万
-
财政年份:1997
-
负责人:TIMOTHY P SKELTON
-
依托单位:
GLYCAN MEDIATED REGULATION OF CD44 FUNCTION
-
批准号:2895789
-
项目类别:
-
资助金额:$8.97万
-
财政年份:1997
-
负责人:TIMOTHY P SKELTON
-
依托单位:
海外基金